Clinical Trials Logo

Clinical Trial Summary

The purpose of the current study is to evaluate the right ventricular function during graded cycling on an ergometer by transthoracic echocardiography in Kyrgyz highlanders with high altitude pulmonary hypertension (HAPH) by performing a cross-sectional case-control study.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03165032
Study type Observational [Patient Registry]
Source University of Zurich
Contact
Status Completed
Phase
Start date May 24, 2017
Completion date August 16, 2017

See also
  Status Clinical Trial Phase
Completed NCT05264324 - Maximal Exercise Capacity at 2500 m of High Altitude N/A
Completed NCT05112172 - Effect of Oxygen Therapy for Patients With Precapillary Pulmonary Hypertension Who Experience an Altitude Related Adverse Health Effect (ARAHE) During 30h Exposure to 2500m N/A
Completed NCT05107700 - Altitude Related Adverse Health Effects (ARAHE) in Patients With Precapillary Pulmonary Hypertension During 30h Exposure to 2500m N/A
Completed NCT05131737 - Exercise Endurance Time on the 2nd Day at 2500 m High Altitude N/A
Completed NCT05089487 - Nocturnal Oxygenation and Sleep-related Breathing Disorders During the First Night of a Stay at 2500m of High Altitude in Patients With Precapillary Pulmonary Hypertension N/A
Completed NCT03165019 - Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.
Completed NCT03172429 - Cerebral Tissue Oxygenation in Highlanders/Lowlanders
Completed NCT03165656 - Right Ventricular Function at Rest in Highlanders/Lowlanders
Completed NCT01566565 - The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary Hypertension Phase 1
Completed NCT01621061 - Sleep Related Breathing Disturbances and High Altitude Pulmonary Hypertension in Kyrgyz Highlanders N/A
Completed NCT01530464 - The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers Phase 1